0.015954
0.009211
0.000000
0.000000
0.018422
0.000000
0.000000
0.000000
0.011977
0.00000
0.00000
0.00000
Swairjo, M.A.
Abdel-Meguid, S.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
62.680
62.680
83.490
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C31 H42 N4 O4
534.690
(2R,4S,5S,1'S)-2-PHENYLMETHYL-4-HYDROXY-5-(TERT-BUTOXYCARBONYL)AMINO-6-PHENYL HEXANOYL-N-(1'-IMIDAZO-2-YL)-2'-METHYLPROPANAMIDE
non-polymer
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
37
10928
10936
10.1021/bi980784h
9692985
Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
1998
US
Biochemistry
BICHAW
0033
0006-2960
36
5128
Identification of a Loop Outside the Active Site Cavity of the Human Immunodeficiency Virus Proteases which Confers Inhibitor Specificity
1997
10.2210/pdb1bdr/pdb
pdb_00001bdr
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
292
1
MIRRORS
IMAGE PLATE
1997-07
MARRESEARCH
NI FILTER
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RUH2R
10669.604
HIV-1 PROTEASE
3.4.23.16
T31S, L33V, E34T, E35G, M36I, S37E
2
man
polymer
534.690
(2R,4S,5S,1'S)-2-PHENYLMETHYL-4-HYDROXY-5-(TERT-BUTOXYCARBONYL)AMINO-6-PHENYL HEXANOYL-N-(1'-IMIDAZO-2-YL)-2'-METHYLPROPANAMIDE
1
syn
non-polymer
18.015
water
56
nat
water
no
no
PQITLWQRPLVTIKIGGQLKEALLDTGADDSVVAGIELPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
PQITLWQRPLVTIKIGGQLKEALLDTGADDSVVAGIELPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lentivirus
IIIB
Escherichia
sample
HIV-1 PROTEASE
11676
Human immunodeficiency virus 1
562
Escherichia coli
BMH 71-18 MUTS
M13MP19PRO4
POTSKF33
1
2.22
45
VAPOR DIFFUSION, HANGING DROP
5.2
HANGING DROP VAPOUR DIFFUSION, BY MIXING EQUAL VOLUMES OF RESERVOIR AND SAMPLE, 21 DEG. C RESERVOIR: 28% 3.5 MG/ML PROTEIN/INHIBITOR COMPLEX AT 1:5 MOLAR RATIO., pH 5.2, vapor diffusion - hanging drop, temperature 294K
294
database_2
pdbx_database_status
struct_ref_seq_dif
struct_site
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1998-10-14
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
1
4
2023-08-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-05-10
REL
REL
IM1
(2R,4S,5S,1'S)-2-PHENYLMETHYL-4-HYDROXY-5-(TERT-BUTOXYCARBONYL)AMINO-6-PHENYL HEXANOYL-N-(1'-IMIDAZO-2-YL)-2'-METHYLPROPANAMIDE
HOH
water
1SBG
PDB ENTRY 1SBG
PDB
experimental model
IM1
400
2
IM1
IM1
400
B
HOH
500
3
HOH
HOH
500
A
HOH
501
3
HOH
HOH
501
A
HOH
503
3
HOH
HOH
503
A
HOH
504
3
HOH
HOH
504
A
HOH
507
3
HOH
HOH
507
A
HOH
508
3
HOH
HOH
508
A
HOH
509
3
HOH
HOH
509
A
HOH
510
3
HOH
HOH
510
A
HOH
511
3
HOH
HOH
511
A
HOH
512
3
HOH
HOH
512
A
HOH
513
3
HOH
HOH
513
A
HOH
518
3
HOH
HOH
518
A
HOH
519
3
HOH
HOH
519
A
HOH
521
3
HOH
HOH
521
A
HOH
526
3
HOH
HOH
526
A
HOH
527
3
HOH
HOH
527
A
HOH
528
3
HOH
HOH
528
A
HOH
529
3
HOH
HOH
529
A
HOH
530
3
HOH
HOH
530
A
HOH
531
3
HOH
HOH
531
A
HOH
532
3
HOH
HOH
532
A
HOH
533
3
HOH
HOH
533
A
HOH
534
3
HOH
HOH
534
A
HOH
536
3
HOH
HOH
536
A
HOH
537
3
HOH
HOH
537
A
HOH
538
3
HOH
HOH
538
A
HOH
539
3
HOH
HOH
539
A
HOH
542
3
HOH
HOH
542
A
HOH
543
3
HOH
HOH
543
A
HOH
546
3
HOH
HOH
546
A
HOH
547
3
HOH
HOH
547
A
HOH
550
3
HOH
HOH
550
A
HOH
552
3
HOH
HOH
552
A
HOH
553
3
HOH
HOH
553
A
HOH
555
3
HOH
HOH
555
A
HOH
502
3
HOH
HOH
502
B
HOH
505
3
HOH
HOH
505
B
HOH
506
3
HOH
HOH
506
B
HOH
514
3
HOH
HOH
514
B
HOH
515
3
HOH
HOH
515
B
HOH
516
3
HOH
HOH
516
B
HOH
520
3
HOH
HOH
520
B
HOH
522
3
HOH
HOH
522
B
HOH
523
3
HOH
HOH
523
B
HOH
524
3
HOH
HOH
524
B
HOH
525
3
HOH
HOH
525
B
HOH
535
3
HOH
HOH
535
B
HOH
540
3
HOH
HOH
540
B
HOH
541
3
HOH
HOH
541
B
HOH
544
3
HOH
HOH
544
B
HOH
545
3
HOH
HOH
545
B
HOH
548
3
HOH
HOH
548
B
HOH
549
3
HOH
HOH
549
B
HOH
551
3
HOH
HOH
551
B
HOH
554
3
HOH
HOH
554
B
HOH
556
3
HOH
HOH
556
B
PRO
1
n
1
PRO
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
THR
4
n
4
THR
4
A
LEU
5
n
5
LEU
5
A
TRP
6
n
6
TRP
6
A
GLN
7
n
7
GLN
7
A
ARG
8
n
8
ARG
8
A
PRO
9
n
9
PRO
9
A
LEU
10
n
10
LEU
10
A
VAL
11
n
11
VAL
11
A
THR
12
n
12
THR
12
A
ILE
13
n
13
ILE
13
A
LYS
14
n
14
LYS
14
A
ILE
15
n
15
ILE
15
A
GLY
16
n
16
GLY
16
A
GLY
17
n
17
GLY
17
A
GLN
18
n
18
GLN
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
GLU
21
n
21
GLU
21
A
ALA
22
n
22
ALA
22
A
LEU
23
n
23
LEU
23
A
LEU
24
n
24
LEU
24
A
ASP
25
n
25
ASP
25
A
THR
26
n
26
THR
26
A
GLY
27
n
27
GLY
27
A
ALA
28
n
28
ALA
28
A
ASP
29
n
29
ASP
29
A
ASP
30
n
30
ASP
30
A
SER
31
n
31
SER
31
A
VAL
32
n
32
VAL
32
A
VAL
33
n
33
VAL
33
A
ALA
34
n
34
ALA
34
A
GLY
35
n
35
GLY
35
A
ILE
36
n
36
ILE
36
A
GLU
37
n
37
GLU
37
A
LEU
38
n
38
LEU
38
A
PRO
39
n
39
PRO
39
A
GLY
40
n
40
GLY
40
A
ARG
41
n
41
ARG
41
A
TRP
42
n
42
TRP
42
A
LYS
43
n
43
LYS
43
A
PRO
44
n
44
PRO
44
A
LYS
45
n
45
LYS
45
A
MET
46
n
46
MET
46
A
ILE
47
n
47
ILE
47
A
GLY
48
n
48
GLY
48
A
GLY
49
n
49
GLY
49
A
ILE
50
n
50
ILE
50
A
GLY
51
n
51
GLY
51
A
GLY
52
n
52
GLY
52
A
PHE
53
n
53
PHE
53
A
ILE
54
n
54
ILE
54
A
LYS
55
n
55
LYS
55
A
VAL
56
n
56
VAL
56
A
ARG
57
n
57
ARG
57
A
GLN
58
n
58
GLN
58
A
TYR
59
n
59
TYR
59
A
ASP
60
n
60
ASP
60
A
GLN
61
n
61
GLN
61
A
ILE
62
n
62
ILE
62
A
LEU
63
n
63
LEU
63
A
ILE
64
n
64
ILE
64
A
GLU
65
n
65
GLU
65
A
ILE
66
n
66
ILE
66
A
CYS
67
n
67
CYS
67
A
GLY
68
n
68
GLY
68
A
HIS
69
n
69
HIS
69
A
LYS
70
n
70
LYS
70
A
ALA
71
n
71
ALA
71
A
ILE
72
n
72
ILE
72
A
GLY
73
n
73
GLY
73
A
THR
74
n
74
THR
74
A
VAL
75
n
75
VAL
75
A
LEU
76
n
76
LEU
76
A
VAL
77
n
77
VAL
77
A
GLY
78
n
78
GLY
78
A
PRO
79
n
79
PRO
79
A
THR
80
n
80
THR
80
A
PRO
81
n
81
PRO
81
A
VAL
82
n
82
VAL
82
A
ASN
83
n
83
ASN
83
A
ILE
84
n
84
ILE
84
A
ILE
85
n
85
ILE
85
A
GLY
86
n
86
GLY
86
A
ARG
87
n
87
ARG
87
A
ASN
88
n
88
ASN
88
A
LEU
89
n
89
LEU
89
A
LEU
90
n
90
LEU
90
A
THR
91
n
91
THR
91
A
GLN
92
n
92
GLN
92
A
ILE
93
n
93
ILE
93
A
GLY
94
n
94
GLY
94
A
CYS
95
n
95
CYS
95
A
THR
96
n
96
THR
96
A
LEU
97
n
97
LEU
97
A
ASN
98
n
98
ASN
98
A
PHE
99
n
99
PHE
99
A
PRO
1
n
1
PRO
1
B
GLN
2
n
2
GLN
2
B
ILE
3
n
3
ILE
3
B
THR
4
n
4
THR
4
B
LEU
5
n
5
LEU
5
B
TRP
6
n
6
TRP
6
B
GLN
7
n
7
GLN
7
B
ARG
8
n
8
ARG
8
B
PRO
9
n
9
PRO
9
B
LEU
10
n
10
LEU
10
B
VAL
11
n
11
VAL
11
B
THR
12
n
12
THR
12
B
ILE
13
n
13
ILE
13
B
LYS
14
n
14
LYS
14
B
ILE
15
n
15
ILE
15
B
GLY
16
n
16
GLY
16
B
GLY
17
n
17
GLY
17
B
GLN
18
n
18
GLN
18
B
LEU
19
n
19
LEU
19
B
LYS
20
n
20
LYS
20
B
GLU
21
n
21
GLU
21
B
ALA
22
n
22
ALA
22
B
LEU
23
n
23
LEU
23
B
LEU
24
n
24
LEU
24
B
ASP
25
n
25
ASP
25
B
THR
26
n
26
THR
26
B
GLY
27
n
27
GLY
27
B
ALA
28
n
28
ALA
28
B
ASP
29
n
29
ASP
29
B
ASP
30
n
30
ASP
30
B
SER
31
n
31
SER
31
B
VAL
32
n
32
VAL
32
B
VAL
33
n
33
VAL
33
B
ALA
34
n
34
ALA
34
B
GLY
35
n
35
GLY
35
B
ILE
36
n
36
ILE
36
B
GLU
37
n
37
GLU
37
B
LEU
38
n
38
LEU
38
B
PRO
39
n
39
PRO
39
B
GLY
40
n
40
GLY
40
B
ARG
41
n
41
ARG
41
B
TRP
42
n
42
TRP
42
B
LYS
43
n
43
LYS
43
B
PRO
44
n
44
PRO
44
B
LYS
45
n
45
LYS
45
B
MET
46
n
46
MET
46
B
ILE
47
n
47
ILE
47
B
GLY
48
n
48
GLY
48
B
GLY
49
n
49
GLY
49
B
ILE
50
n
50
ILE
50
B
GLY
51
n
51
GLY
51
B
GLY
52
n
52
GLY
52
B
PHE
53
n
53
PHE
53
B
ILE
54
n
54
ILE
54
B
LYS
55
n
55
LYS
55
B
VAL
56
n
56
VAL
56
B
ARG
57
n
57
ARG
57
B
GLN
58
n
58
GLN
58
B
TYR
59
n
59
TYR
59
B
ASP
60
n
60
ASP
60
B
GLN
61
n
61
GLN
61
B
ILE
62
n
62
ILE
62
B
LEU
63
n
63
LEU
63
B
ILE
64
n
64
ILE
64
B
GLU
65
n
65
GLU
65
B
ILE
66
n
66
ILE
66
B
CYS
67
n
67
CYS
67
B
GLY
68
n
68
GLY
68
B
HIS
69
n
69
HIS
69
B
LYS
70
n
70
LYS
70
B
ALA
71
n
71
ALA
71
B
ILE
72
n
72
ILE
72
B
GLY
73
n
73
GLY
73
B
THR
74
n
74
THR
74
B
VAL
75
n
75
VAL
75
B
LEU
76
n
76
LEU
76
B
VAL
77
n
77
VAL
77
B
GLY
78
n
78
GLY
78
B
PRO
79
n
79
PRO
79
B
THR
80
n
80
THR
80
B
PRO
81
n
81
PRO
81
B
VAL
82
n
82
VAL
82
B
ASN
83
n
83
ASN
83
B
ILE
84
n
84
ILE
84
B
ILE
85
n
85
ILE
85
B
GLY
86
n
86
GLY
86
B
ARG
87
n
87
ARG
87
B
ASN
88
n
88
ASN
88
B
LEU
89
n
89
LEU
89
B
LEU
90
n
90
LEU
90
B
THR
91
n
91
THR
91
B
GLN
92
n
92
GLN
92
B
ILE
93
n
93
ILE
93
B
GLY
94
n
94
GLY
94
B
CYS
95
n
95
CYS
95
B
THR
96
n
96
THR
96
B
LEU
97
n
97
LEU
97
B
ASN
98
n
98
ASN
98
B
PHE
99
n
99
PHE
99
B
author_and_software_defined_assembly
PISA
2
dimeric
4960
-28
9240
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ILE
3
A
O
ILE
3
B
N
LEU
97
B
N
LEU
97
B
O
THR
96
B
O
THR
96
A
N
ASN
98
A
N
ASN
98
A
O
VAL
11
A
O
VAL
11
A
N
ALA
22
A
N
ALA
22
1
A
PRO
79
-69.38
81.44
1
B
PRO
79
-56.22
31.00
PARHCSDX.PRO
TOPHCSDX.PRO
PARAM19.SOL
TOPH19.SOL
IM1.PARAM
IM1.TOPOL
PARAM19X.PRO
TOPH19X.PRO
17.5
17.5
17.5
17.5
17.5
17.5
17.5
0.2550000
0.02
0.2010000
0.2010000
2.8
20.0
412
4054
10.0
95.6
RANDOM
0.0
1
RESTRAINED
THROUGHOUT
0.0
DIFFERENCE FOURIER
PDB ENTRY 1SBG
0.25
2.8
20.0
4
1584
78
0
1502
0.019
3.4
29.2
1.8
2.93
400
8
74.0
2.5
20.0
1BDR
6058
1.0
0.1200000
0.1200000
1
9.0
7.4
99.8
0.5300000
2.5
2.57
5.1
0.5300000
7.3
67.1
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data reduction
DENZO
data scaling
SCALEPACK
phasing
X-PLOR
3.1
HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
A
ARG
87
A
ARG
87
HELX_P
A
ILE
93
A
ILE
93
1
1
7
B
ARG
87
B
ARG
87
HELX_P
B
LEU
90
B
LEU
90
1
2
4
HYDROLASE
HYDROLASE, AIDS, POLYPROTEIN, ASPARTYL PROTEASE, ACID PROTEASE, HYDROXYETHYLENE ISOSTERE INHIBITOR, SUBSTRATE ANALOGUE INHIBITOR
POL_HV1B5
UNP
1
1
P04587
FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQITLWQRPLVT
IKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQ
IGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK
LVDFRELNRRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGSGYQYNVLPQGW
KGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYE
LHPDKWTIQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP
VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPI
QKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAASRETKLGKAGYVTNRGRQKVVTLTHTT
NQKTELQAIHLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVS
AGIRKILFLDGIDKAQEEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVI
LVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVES
MNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP
LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED
69
167
1BDR
1
99
P04587
A
1
1
99
69
167
1BDR
1
99
P04587
B
1
1
99
1
THR
engineered mutation
SER
31
1BDR
A
P04587
UNP
99
31
1
LEU
engineered mutation
VAL
33
1BDR
A
P04587
UNP
101
33
1
GLU
conflict
ALA
34
1BDR
A
P04587
UNP
102
34
1
GLU
engineered mutation
GLY
35
1BDR
A
P04587
UNP
103
35
1
MET
engineered mutation
ILE
36
1BDR
A
P04587
UNP
104
36
1
SER
engineered mutation
GLU
37
1BDR
A
P04587
UNP
105
37
2
THR
engineered mutation
SER
31
1BDR
B
P04587
UNP
99
31
2
LEU
engineered mutation
VAL
33
1BDR
B
P04587
UNP
101
33
2
GLU
conflict
ALA
34
1BDR
B
P04587
UNP
102
34
2
GLU
engineered mutation
GLY
35
1BDR
B
P04587
UNP
103
35
2
MET
engineered mutation
ILE
36
1BDR
B
P04587
UNP
104
36
2
SER
engineered mutation
GLU
37
1BDR
B
P04587
UNP
105
37
3
2
anti-parallel
anti-parallel
anti-parallel
A
GLN
2
A
GLN
2
A
THR
4
A
THR
4
B
THR
96
B
THR
96
B
ASN
98
B
ASN
98
A
THR
96
A
THR
96
A
ASN
98
A
ASN
98
A
LEU
10
A
LEU
10
A
ILE
15
A
ILE
15
A
GLN
18
A
GLN
18
A
LEU
23
A
LEU
23
IM1 BINDING SITE.
Unknown
2
BINDING SITE FOR RESIDUE IM1 B 400
B
IM1
400
Software
16
A
ASP
29
A
ASP
29
2
1_555
B
ASP
29
B
ASP
29
2
1_555
A
ARG
8
A
ARG
8
16
1_555
A
ASP
25
A
ASP
25
16
1_555
A
GLY
27
A
GLY
27
16
1_555
A
ALA
28
A
ALA
28
16
1_555
A
ASP
29
A
ASP
29
16
1_555
A
GLY
48
A
GLY
48
16
1_555
A
GLY
49
A
GLY
49
16
1_555
A
VAL
82
A
VAL
82
16
1_555
B
ASP
25
B
ASP
25
16
1_555
B
GLY
27
B
GLY
27
16
1_555
B
ALA
28
B
ALA
28
16
1_555
B
ASP
29
B
ASP
29
16
1_555
B
GLY
48
B
GLY
48
16
1_555
B
GLY
49
B
GLY
49
16
1_555
B
ILE
50
B
ILE
50
16
1_555
B
HOH
525
E
HOH
16
1_555
169
P 61